Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline
- 1 December 2013
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 254, 110-119
- https://doi.org/10.1016/j.neuroscience.2013.09.023
Abstract
No abstract availableKeywords
Funding Information
- Defence Research and Development Organization, Ministry of Defence, Government of India
- Department of Science and Technology, Government of India
This publication has 61 references indexed in Scilit:
- Inhibition of glucocorticoid receptors ameliorates hypobaric hypoxia induced memory impairment in ratBehavioural Brain Research, 2013
- Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network SynapsesNeuron, 2012
- Catecholamine and Second Messenger Influences on Prefrontal Cortical Networks of "Representational Knowledge": A Rational Bridge between Genetics and the Symptoms of Mental IllnessCerebral Cortex, 2007
- Essential Role for the PKC Target MARCKS in Maintaining Dendritic Spine MorphologyNeuron, 2005
- Protein Kinase C Overactivity Impairs Prefrontal Cortical Regulation of Working MemoryScience, 2004
- Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in ratsPharmacology Biochemistry and Behavior, 2000
- Through the Looking Glass: Differential Noradenergic Modulation of Prefrontal Cortical FunctionNeural Plasticity, 2000
- The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypesJournal of Neuroscience, 1988
- Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence convergTrends in Pharmacological Sciences, 1988
- HYPOXIC BRAIN DAMAGEBritish Journal of Anaesthesia, 1975